Are you a public company looking for exposure?
Contact RealPennies.com - 1.800.940.6559
For more info: http://wifm.realpennies.com
Mar 11, 2008 -- WiFiMed Holdings Company, Inc. ("WiFiMed Holdings") (PINKSHEETS: WIFM), a leading provider of physician workflow solutions, announced today that its wholly owned subsidiary, EncounterPRO Healthcare Resources, Inc., has successfully completed the comprehensive testing and certification process for SureScripts certification and is now a SureScripts Certified Solution Provider(TM).
As a SureScripts Certified Solution Provider(R), EncounterPRO's physician clients who utilize the EncounterPRO(R) EHR product can now connect to the Pharmacy Health Information Exchange(TM), operated by SureScripts(R). The Pharmacy Health Information Exchange allows physicians and pharmacists to electronically exchange prescription information and electronically transmit new prescriptions and refill requests during routine and emergency care.
"We are very pleased to have become a SureScripts Certified Solution Provider," said Greg Vacca, Chief Executive Officer of WiFiMed Holdings. "The unique workflow engine of EncounterPRO EHR will help set it apart from any other product in the market as it will take e-prescribing to a new level of convenience for both physicians and patients. SureScripts certification enables EncounterPRO physicians and users to send new prescriptions to a patient's pharmacy, receive renewal requests back, and send renewal approvals directly from within EncounterPRO EHR, making the prescription process much safer and more efficient. I am proud of the outstanding efforts of our development staff in this achievement."
EncounterPRO's e-prescribing module replaces antiquated and error-prone methods for prescribing. With more than 95 percent of all pharmacies in the US being certified on the Pharmacy Health Information Exchange(TM) and approximately two-thirds processing prescriptions electronically, the risk of medication errors associated with poor handwriting, illegible faxes, similar named drugs, and manual data entry is greatly reduced through the e-prescribing feature of the EncounterPRO EHR 5.0.
If you would like to be added to WiFiMed Holdings' investor email list, please contact Zack Noory with Nexus Investor Relations at znoory@nexusir-online.com.
About SureScripts
Founded by the pharmacy industry in 2001, SureScripts operates the Pharmacy Health Information Exchange(TM), which facilitates the secure electronic transmission of prescription information between physicians and pharmacists and provides access to lifesaving information about patients during emergencies or routine care. More information about SureScripts is available at www.surescripts.com.
About WiFiMed Holdings Company, Inc.
WiFiMed Holdings Company, Inc., through its wholly-owned subsidiaries WiFiMed, Inc. and EncounterPRO Healthcare Resources, Inc., offers proprietary solutions enabling physicians and other healthcare providers to document the physician-patient encounter through continuously updated state-of-the-art technologies. WiFiMed Inc.'s proprietary product, Tablet MD(R) Record and EncounterPRO Healthcare Resources, Inc's proprietary product, EncounterPRO(R) EHR, were developed to assist physicians and health care providers manage patient workflow. Tablet MD(R) operates on a tablet PC and manages patient medical information, consultation notes, prescriptions, records, and charts through five proprietary technologies. The EncounterPRO(R) EHR gives physicians and staff the most flexible and sophisticated workflow engine available in an EHR. This premier software requires virtually no level of computer literacy and works off touch screens, PC Tablets or a mouse as the primary means of data input. Both products have been designed to meet the Health Insurance Portability and Accountability Act (HIPAA) requirements and are designed to reduce medical errors, documentation time, overhead, and time spent filing insurance claims.
EncounterPRO(R) EHR 5.0 is CCHIT certified for Ambulatory Care 2006. EncounterPRO Healthcare Resources is also a SureScripts Certified Solution Provider(TM).
For more info: http://onco.realpennies.com
Mar 10, 2008 -- Oncology Med, Inc. (PINKSHEETS: ONCO) announced its unaudited results for the fiscal year 2007 shows a 14% increase in revenues to $ 1,745,606.00 from $ 1,536,100.00 for the fiscal year ended 2006. The Company had a net loss of only ($ 76,572.00) for the fiscal year ended 2007 as compared to a net loss of ($ 213,310.00) for fiscal year 2006.
Dr. William J. Walker, chairman of Oncology Med, Inc., stated, "I am extremely pleased with our results for 2007. We have achieved a substantial increase in revenue for fiscal year 2007 over the same period last year. We will have revenues in excess of $ 2,000,000.00 for fiscal year 2008 in addition to achieving net income for the period."
About Oncology Med, Inc.
Oncology Med is a public company engaged in the fulfillment of services related to the treatment of various cancers. It currently provides analysis and design of radiation treatment plans in order for radiation oncologists to administer radiation plans to cancer patients.
Current services facilitate radiation treatment programs ranging from external beam radiation to more advanced radiation treatment technologies.
Mar 12, 2008 -- Extreme Fitness Inc. (PINKSHEETS: EXTF) has recently added local producer Brian Sissom to film videos showcasing new and future EXTF merchandise. The new merchandise is currently in the production phase and should be ready in the near future.
Brian Sissom, a graduate of the UCLA film school, has been working on films for the past twenty-five years and as a movie producer has made horror movies, documentaries, and infomercials.
"The filming will be a breeze for Brian due to his vast experience in the film industry," stated Vice President John Huerta. "We are really looking forward to working with him."
ABOUT EXTREME FITNESS INC.
I M & M Exercise Equipment, wholly owned subsidiary of Extreme Fitness Inc., founded in 1974, manufacturing since 1983, designs, manufactures and distributes strength training and fitness equipment in the emerging exercise equipment market. Frank Huerta, with sons Tom and John, capitalized on their sophisticated machining and manufacturing skills to engineer what rapidly became established as the premier exercise equipment on the market. The trio self-engineered and designed hundreds of products and implemented manufacturing processes for all stages of development and production. High profile clients continue to demand their products and services such as the United States Olympic Training Centers, Colleges and Universities, Professional Sports Teams, Major Chain Health Clubs as well Celebrities and Professional athletes and coaches. The trio brings more than 66 years of combined experience and over 3 decades of successful business in the fitness industry.
For more info: http://cvsc.realpennies.com
Mar 12, 2008 -- Cardiovascular Sciences, Inc. (PINKSHEETS: CVSC), a client company of the award winning University of Central Florida Technology Incubator program, was selected for the Advanced Invention to Venture training and assistance. This is an intense, practical oriented course facilitated by Courtney Price and Mack Davis, cofounders of Venture Quest, Ltd. (http://www.venturequestltd.com) and co-authors of the entrepreneur's textbook, "Fueling Innovation." Entrepreneurship training materials developed by Ms. Price and Mr. Davis have been selected as the best entrepreneurship training available in the country by the Kaufman Foundation of Kansas City, MO.
The program begins with an intensive four-day workshop that is held around the country several times a year for a half dozen invited companies, all at various stages of development. The program is presented as part of a contract Venture Quest Ltd. has with the National Collegiate Inventors and Innovators Alliance (NCIIA, http://www.nciia.org). Following successful completion of the initial program, there is a six to eight week customized assistance and mentoring program provided to the individual companies. This phase is mentored by any of a number of previously successful entrepreneurs who have taken an idea from creation to market. The goal is to help a company outline a plan of commercialization of their technologies from out of the laboratory and into the marketplace. This particular conference was hosted by the UCF Technology Incubator in their brand new Winter Springs Technology Incubator facility. Five other companies from areas as far away as Virginia were selected and attended this program.
The overall goal of this valuable program is to help companies identify and develop marketable technologies, bringing them out of the laboratory and launching them successfully into the marketplace. A series of online diagnostic tools developed by Venture Quest Ltd. are made available to the companies to assist the participating companies in developing and expanding their organizational, operational and commercialization plans. There is an emphasis on the rapid commercialization of the technology. Included in the training and assessment is a review of many of the various strategies for funding, protecting intellectual property and options possible for licensing and distribution.
The four-day rigorous curriculum culminates with the participating companies making targeted presentations before a group of investors and entrepreneurial professionals.
"This workshop was intense but the material is invaluable," described Dr. Hooper following the successful completion of the in-depth four-day workshop. "The process of carrying an invention from the lab all the way to the marketplace is covered step-by-step. I feel something like this is essential for any small company in order to effectively and efficiently commercialize their first technologies." He goes on to add, "I am really looking forward to the continued assistance provided by the individualized mentoring to assist us in continuing to moving forward from here."
About Cardiovascular Sciences
Cardiovascular Sciences, Inc. is an advanced medical device company which is developing a novel technology platform to address the problem of post-surgical and post-traumatic adhesions. Adhesions and the complications of adhesions are a significant problem worldwide for a wide range of specialists, including general surgeons, cardiothoracic surgeons, orthopedic, plastic, and ophthalmologic and otolaryngology specialists to name just some of them. In addition, the veterinary field has a tremendous need for a product that can prevent similar problems in a wide variety of animals. The Company's unique materials and processes promise a more cost-effective and decidedly more efficient and capable means to deal with a problem that has been so devastating to so many. Current sponsored research at the University of Central Florida (UCF) and previously at other institutions indicate that The Company is on the right path and progressing well.
In addition to the anti-adhesion technology, The Company owns technology in a variety of other areas, including thrombo-resistant coatings, enhanced intra-arterial balloon pumping catheters, cell engineered vascular tissues, and a method for improved recovery of the heart following cardioplegia. This yields a diversified portfolio with projects in various stages of development.
For more info: http://blln.realpennies.com
March 12, 2008 -- Brilliant Technologies Corp. (PINKSHEETS: BLLN) Digital distribution industry leader finetunes and Qtrax, the world's first free and legal peer-to-peer (P2P) music service, today announce that they have signed a digital licensing agreement.
For more than four years, finetunes has been a pioneer in creating opportunities for independent labels in the digital music markets.
Initially focused on providing digital solutions for the German independent labels, the Hamburg-based company now represents more than 1,000 record labels from around the world.
A leading distributor in the field of electronic music, finetunes also represents labels from across the musical spectrum, from jazz to reggae, pop to world music. finetunes stands out from other digital distributors in that it handles all its technical development and operations in-house, giving the company the ability to react fast and innovate -- providing labels with solutions such as its recently-launched sales tracking software, enabling its partners to gain a detailed overview of their position in the digital market
Also at the heart of finetunes operation is its global network of satellite offices, which work together with finetunes HQ to secure strategic, focused and truly coordinated international retail marketing for new releases. Furthermore, finetunes is developing new and innovative solutions for catalogue marketing, and also focusing on providing digital marketing opportunities for labels outside of the core market of digital music stores.
"finetunes has been at the forefront of the evolving music market online," said Founder and Chairman of Qtrax Allan Klepfisz. "They truly pioneered digital distribution and have shown great vision. We are delighted to be able to offer finetunes' catalogue of top artists and songwriters."
About finetunes (http://www.finetunes.net)
For more than four years, finetunes has been a pioneer in creating opportunities for independent labels in the digital music markets.
Initially focused on providing digital solutions for the German independent labels, the Hamburg-based company now represents more than 1,000 record labels from around the world and has a network of satellite offices in London, Paris, Montreal, Tokyo and Barcelona.
About Qtrax (http://www.qtrax.com)
For more info: http://blln.realpennies.com
Qtrax is the world's first legal and free peer-to-peer (P2P) music service. Qtrax showcases an innovative ad-supported delivery model that easily directs revenue back to artists and rights holders. Qtrax is available for browsing now and soon will provide fans with access to a colorful and diverse catalog with millions of high-quality digital music files representing the broadest artist-based fan-directed array of products available anywhere. Based in New York City, Qtrax is a subsidiary of Brilliant Technologies Corporation (OTC: BLLN.PK), a publicly traded technology holding company.
For more info: http://axvc.realpennies.com
March 11, 2008 -- Axial Vector Engine Corporation (Pink Sheets: AXVC) (Frankfurt: BAE1) announced the arrival of its 200 KW GENSET to Dubai for the WETEX energy show that will continue through to Thursday, March 13.
Local newspapers published interviews with Mr. Ahmed Khalifa, Chairman of AVEC who discussed the revolutionary implications of the first multi-fuel engine and generators capable of producing "Carbon Credits" while at the same time producing low cost mobile power.
The ability to add a second stream of income, by selling carbon credits, to a power generation scenario represents a new era in generator development.
Carbon credits are valued currently at 15 Euros and are forecast to skyrocket in future years as the global warming epidemic continues. Our Gensets are the only multi-fuel 200kw units qualified for these credits.
The urgency of reducing carbon emissions to combat global warming is well-addressed with the introduction of the AVEC technologies.
Pictures of the GENSET on display at the WETEX show can now be viewed on the company's website at http://www.axialvectorengine.com.
Mr. Ahmed Khalifa, Chairman of AVEC stated, "There is a significant need for portable multi-fuel power that can be produced and deployed quickly and in very large quantities that also lower the carbon and pollution gases. We are proud to introduce this new solution to a world problem in my home country of Dubai."
Axial Vector(TM) Engine Corporation is a publicly traded company (Pink Sheets: AXVC.PK) that owns, develops and licenses proprietary intellectual property regarding unique internal combustion engine technologies. AVEC is applying these technologies to develop an exciting, new, smaller and lighter internal combustion engine that produces significantly greater horsepower and three times more torque on less fuel than conventional engines of similar size.
Read our full disclaimer at: http://www.realpennies.com/start.html
Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned on RealPennies. For more movers: http://www.realpennies.com/wrapup.html
Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice.
Sitemap: http://www.realpennies.com/sitemap.html
Sponsored by: http://www.isthemarketopen.com
RealPennies .
Telephone: 1-800-940-6559
Matt /at/ realpennies.com
